From Glofish to Frankenfish: Understanding How the Approval of Transgenic Animals May Impact Animal and Human Food and Drugs
Joseph W. Cormier
Attorney
Hyman, Phelps & McNamara, P.C. (Washington, DC)
GMO Salmon was approved for human consumption last fall via a New Animal Drug Application. This panel will explore the controversial nature of this approval as well as its wider implication for animal and human food and drugs.
- Review and analysis of the approval process for transgenic animals through use of a NADA
- understanding why a potential food is approved as an animal drug
- Glofish exemption v. AquAdvantage NADA Approval
- differences and controversies
- Implications for what new animal drug approval for transgenic animals such as AquAdvantage salmon will have on animal and human foods chain
- Exploring the labeling controversy for AquAdvantage salmon and other GMO foods in both the animal and human food industries